After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
Advanced Micro Devices (AMD) rose 9% after reporting Q3 earnings of $2.09 per share on $13.38B revenue, beating estimates, and raising Q4 revenue guidance to $17B. Super Micro Computer (SMCI) jumped 7% on strong Q1 results and raised full-year revenue outlook. Skyworks Solutions (SWKS) fell 15% on mixed Q4 results and weak guidance. Nurix Therapeutics (NRIX) dropped 30% after Sanofi ended a clinical trial. Toast (TOST) slid 5.5% on Q3 earnings miss.
How this was made
The 30-second read
Why it matters
Earnings beats with strong guidance (AMD, SMCI) drive upside, while guidance misses or partnership terminations (SWKS, NRIX, TOST, BKNG) generate downside pressure.
Market read
The earnings releases collectively shape short‑term sentiment in AI‑hardware, biotech, and travel sectors, influencing after‑hours trading and potentially setting the tone for the next trading day.
What to watch
Supply‑chain constraints for AI hardware and potential macro‑headwinds could temper the rally.
Background
The article aggregates after‑hours price moves tied to fresh quarterly earnings and guidance updates for six U.S. listed companies.
Ticker impact
AMD posted Q3 EPS $2.09 beating $1.94 consensus and raised Q4 revenue guidance to $17.0B, driving a 9% after‑hours gain.
likely upside as market prices in the earnings beat and higher guidance
The beat was sizable (+$0.15 EPS) and guidance topped expectations, prompting a 9% move.
Super Micro reported Q1 EPS $1.81 vs $1.23 estimate and lifted FY2027 revenue outlook to $72‑$82B, sending shares up 7% after hours.
likely upward as investors digest the strong top‑line and guidance lift
EPS beat of $0.58 and a revenue outlook well above consensus drove a sizable price jump.
Skyworks posted Q4 EPS $1.28 vs $1.27 consensus but gave weak FY2027 guidance, causing a 15% after‑hours decline.
likely pressure as market prices in the soft outlook
Revenue and EPS guidance fell short of expectations, leading to a sharp sell‑off.
Nurix shares fell 30% after Sanofi cancelled a Phase 1 trial and terminated the partnership, removing future milestone payments.
likely continued decline as cash‑flow outlook deteriorates
Termination of the Sanofi deal eliminates expected future revenue, triggering a large price drop.
Toast missed Q3 EPS expectations ($0.29 vs $0.37) and gave modest Q4 guidance, resulting in a 5.5% after‑hours slide.
likely pressure as investors reassess growth prospects
The EPS miss of $0.08 and weaker guidance drove the sell‑off.
Booking posted Q3 EPS $4.66 beating $4.49 but missed revenue ($8.90B vs $9.54B), leading to a 2% after‑hours decline.
likely slight pressure as revenue shortfall dominates sentiment
Revenue miss outweighed the earnings beat, resulting in a modest price drop.
Market effects
AI‑related hardware and cloud services sectors see heightened interest from strong earnings, while biotech faces setback from partnership loss.
U.S. tech and consumer‑services indices may see modest moves in after‑hours trading.
Mixed earnings across major U.S. names could influence global risk sentiment in the AI and travel sectors.
Counterpoint
Despite strong earnings, elevated valuations may limit upside; consider profit‑taking on AMD and SMCI.
Key entities
- companyAdvanced Micro Devices
Semiconductor maker reporting Q3 beat and raised FY guidance.
- companySuper Micro Computer
AI server manufacturer delivering strong Q1 results and raised outlook.
- companySkyworks Solutions
RF semiconductor firm with mixed Q4 results and weak FY guidance.
- companyNurix Therapeutics
Biotech losing Sanofi partnership, causing revenue loss.
- companyToast
Restaurant‑tech platform missing Q3 EPS expectations.
